Paradigm Biopharmaceuticals | PAR - Net Income

Stock Price
0.31
Daily Change
0.01 1.67%
Monthly
-15.28%
Yearly
-36.46%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-6.42M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Avita Medical AUD -9.92M 1.67M Jun/2025
Medical Developments International AUD -105K 409K Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024